Rx Pricing Restraint Continues After Elections, AmerisourceBergen Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The wholesaler lowers its fiscal year earnings forecast because a post-election uptick in manufacturer price increases has not accelerated in December. ABC remains confident that prices will rise 5% during the remainder of its fiscal year ahead of the January 2006 start of the Medicare drug benefit.